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Autographa californica nuclear polyhedrosis virus (AcNPV) was used as an
expression vector for human beta interferon. By using specially constructed
plasmids, the protein-coding sequences for interferon were linked to the AcNPV
promoter for the gene encoding for polyhedrin, the major occlusion protein. The
interferon gene was inserted at various locations relative to the AcNPV polyhe-
drin transcriptional and translational signals, and the interferon-polyhedrin hybrid
genes were transferred to infectious AcNPV expression vectors. Biologically
active interferon was produced, and greater than 95% was secreted from infected
insect cells. A maximum of ca. 5 x 106 U of interferon activity was produced by
106 infected cells. These results demonstrate that AcNPV should be suitable for
use as a eucaryotic expression vector for the production of products from cloned
genes.
Autographa californica nuclear polyhedrosis
virus (AcNPV) has a genome of ca. 130 kilo-
bases of double-stranded, circular DNA and is
the most extensively studied baculovirus (for
recent reviews see references 13 and 20). Its
host range is limited to lepidoptera species and
cultured lepidoptera cells, and it is currently
being considered for agricultural use as a viral
insecticide. AcNPV has a biphasic replication
cycle and produces a different form of infectious
virus during each phase. Between 10 and 24 h
postinfection (p.i.), extracellular virus is pro-
duced by the budding of nucleocapsids through
the cytoplasmic membrane. By 15 to 18 h p.i.,
nucleocapsids are enveloped within the nucleus
and viral occlusions begin to form. Each occlu-
sion contains many virus particles embedded in
a paracrystalline protein matrix, which is formed
from a single major protein called polyhedrin. In
infected Spodopterafrugiperda (fall armyworm,
Lepidoptera, Noctuidae) cells, AcNPV polyhe-
drin accumulates to high levels and constitutes
25% or more of the total protein mass in the cell
(34); it is probably synthesized in greater abun-
dance than any other protein in a virus-infected
eucaryotic cell.
Polyhedrin is encoded by the virus (40), and
the gene has been mapped (34) and sequenced
(B. J. L. Hooft van Iddekinge, G. E. Smith, and
M. D. Summers, Virology, in press). From an
analysis of viral deletion mutants, we demon-
strated that the polyhedrin gene is not required
for the production of infectious extracellular
virus (30). Inactivation of the polyhedrin gene by
deletion (30) or, as will be demonstrated in this
report, by insertion results in mutants that do
not produce occlusions in infected cells. These
occlusion-negative viruses form plaques that are
different from plaques produced by wild-type
viruses, and this distinctive plaque morphology
is used as a means to screen for recombinant
viruses (30).
Several properties of AcNPV that may make
this virus ideally suited as an expression vector
for cloned eucaryotic genes have been described
(20). These include the potential of the rod-
shaped virus to encapsidate viral genomes with
large pieces of additional, foreign DNA and the
inherent safety of a recombinant viral vector
that is not pathogenic to vertebrates. In addi-
tion, the polyhedrin gene provides: (i) a nones-
sential region of the AcNPV genome in which to
insert foreign DNA, (ii) a very strong promoter
which directs transcription late in infection after
extracellular virus is produced and after host
genes and most viral genes are turned off, and
(iii) a genetic marker to select for recombinant
viruses. To examine the utility of AcNPV as an
expression vector, we fused the gene for human
beta interferon (IFN-P) to the AcNPV polyhe-
drin promoter and measured its production in
infected cells.
IFN-3 is known to have antiviral, antiprolifer-
ative, and antitumor properties and should
prove important in a variety of medical applica-
tions. Although cultured human cells normally
do not produce interferon, treatment with induc-
ers such as viruses or double-stranded RNA
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results in a transient and relatively low-level
biosynthesis of IFN-, (35). The IFN-3 gene has
been expressed in Escherichia coli cells by fus-
ing interferon protein-coding sequences to bac-
terial promoter and ribosomal binding sites in
plasmid (8, 37) or lambda phage (22) vectors.
Nonhuman mammalian cells have also been
employed to synthesize IFN-, from the cloned
gene. For example, the IFN-P gene has been
cloned with its protein-coding sequences under
the transcriptional control of a simian virus 40
promoter (7), a herpes simplex virus thymidine
kinase promoter (25), or its own genetic signals
(2, 11, 21, 24, 43). The highest reported levels of
beta interferon activity produced in bacterial
and animal host-vector systems are 1 x 104 U/ml
in E. coli cells (8) and 5 x 104 U/ml in trans-
formed mouse cells (11). By using AcNPV as an
expression vector, biologically active IFN-P
was efficiently secreted in the media of infected
cells and reached a titer of 5 x 106 U/ml. In
addition, the IFN-3 protein was glycosylated,
and our data indicate that the signal peptide at
the amino-terminal end of the primary transla-
tion product was removed.
MATERIALS AND METHODS
Cells and virus. AcNPV stocks were grown and
titers were determined in S. frugiperda cells (IPLB-
SF21-AE), using Hink medium (12) plus 10%o fetal
bovine serum (FBS) as described previously (31).
Human amnionic (WISH) cells were maintained in
Earle minimum essential medium supplemented with
penicillin (100 U/ml), mycostatin (50 U/ml), and 15%
FBS.
Interferon. Interferon activity was determined by
the virus plaque-reduction assay (18) in WISH cells
challenged with vesicular stomatitis virus. Serial dilu-
tions (0.5 log) of culture media from recombinant
AcNPV-infected cells were made over 2.5 x 104
WISH cells in 96-well microtiter plates. After 12 h at
37°C, each well was infected with ca. 60 PFU of
vesicular stomatitis virus, and the cells were overlaid
with 0.5% methyl cellulose in Earle minimum essential
medium. At 24 h p.i., the cell monolayers were stained
with crystal violet and the plaques were counted. An
international reference standard of human interferon
was included in all assays, and the activity was ex-
pressed in National Institutes of Health reference units
(IU) per milliliter.
Transfection and selection for recombinant viruses.
The procedure used to transfect S. frugiperda cells
and the marker-transfer method used to select for
recombinant AcNPV expression vectors were as de-
scribed previously (30).
Protein blot radioimmunoassay. Total cellular pro-
teins were electrophoretically separated and then re-
acted with antibody as described previously (32). At 30
h p.i., cells were washed with 1 x phosphate-buffered
saline and ca. 100-p.g samples of cell protein were
electrophoresed on a sodium dodecyl sulfate-12%
polyacrylamide gel (12) and then transferred by diffu-
sion to two nitrocellulose filters. The filters were
incubated with either a 1:1,000 dilution of rabbit
antiserum prepared against AcNPV polyhedrin (32) or
a 10-pLg/ml concentration of monoclonal antibody to
recombinant IFN-P (Hoffmann-La Roche Inc., Nut-
ley, N.J.). Specifically bound antibody was detected
by using radioiodinated Staphylococcus aureus pro-
tein A.
Radiolabeling of infected cells and analysis of poly-
peptides. At various times after infection, cells were
labeled for 30 min in leucine-free Grace medium (9)
supplemented with 2% dialyzed FBS and L-[3H]leu-
cine at 100 pRCi/ml or for 60 min in Grace medium with
10o the normal glucose supplemented with 2% dia-
lyzed FBS and D-[2-3H]mannose at 200 uCi/ml. To
label cells in the presence of tunicamycin, infected
cells were pretreated for 20 to 30 h p.i. with 5 ,ug of
tunicamycin per ml and then labeled as described
above with L-[PH]leucine in the presence of 5 ,ug of
tunicamycin per ml. The labeled cells were washed
with Grace medium, disrupted and electrophoresed on
sodium dodecyl sulfate-12% polyacrylamide gels, and
then processed for fluorography as described previ-
ously (33). Molecular weights were calculated by
comparing electrophoretic mobility with that of pro-
tein markers (Pharmacia Fine Chemicals, Piscataway,
N.J.).
Construction of AcNPV transfer vectors. AcNPV
EcoRI-I, which contains the polyhedrin gene (1, 26,
33), was cloned into the EcoRI site of pUC8 (41). The
resulting plasmid (pI8) has three BamHI recognition
sites: one in the polyhedrin gene, one in EcoRI-I
downstream from the polyhedrin gene, and one in the
cloning region of pUC8. The BamHI site in pUC8 was
removed by digesting p18 successively with PstI,
SmaI, and S1 nuclease. E. coli JM83 cells were
transformed with the digested DNA, and a plasmid
was isolated that was missing PstI, BamHI, SmaI, and
EcoRI restriction sites in the cloning region of pUC8.
This plasmid was partially digested with BamHI, and
full-length linear DNA was isolated from an agarose
gel, treated with S1 nuclease (500 U/ml) at 37°C for 15
min, circularized with T4 DNA ligase, and used to
transform JM83 cells. A plasmid (pAc101) was identi-
fied with a single BamHI site located ca. 220 bases
from the polyhedrin transcriptional start site (Fig. 1;
34).
The following procedure was used to modify pAclOl
such that some or all of the DNA sequences between
the transcriptional start site and the BamHI recogni-
tion sequence in the polyhedrin gene were deleted and
replaced by a synthetic BamHI linker sequence, 5'-
dCGGATCCG-3' (P-L Biochemicals, Inc., Milwau-
kee, Wis.). The EcoRI-to-BamHl fragment in AcNPV
EcoRI-I (located 0 to 4,210 bases in EcoRI-I; see
reference 34) was cloned into pUC8. Forty micro-
grams of this plasmid (pB') was digested with BamHI
and then incubated for 40 min at 30°C with 0.5 U ofBal
31 exonuclease. At 4-min intervals, 10-p.l samples
were removed, and the reaction was stopped by add-
ing 10 jil of 0.025 M EDTA. The samples were pooled,
phenol extracted, and precipitated with 2 volumes of
ethanol. The ends of the DNA were repaired by
incubating the DNA in 100 ,ul for 30 min at 23°C with 4
U of E. coli DNA polymerase (Klenow fragment).
Phosphorylated BamHI linkers were added to the ends
with T4 DNA ligase, the fragments were digested with
BamHI and EcoRl, and truncated pB' fragments with
ca. 100- to 400-base-pair deletions were isolated from
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GGTCTGCGAGCAGTTGTTTGTTGTTAAAAATAACAGCCATTGTAATGAGACGCACAA-ACTAATAATCACMAyCTGGAAAATGTIACAAlTAGTT
-198 -142 -128 -110
pAc380OL
GCTATA GGCC ATCTC AAATAAGTATTTTACTGTTTTCGTAACAGTTTTGTAATAAAAAAACCTATAAATA
-99EC-ow-78 -58
pro asp tyr ser tyr arg pro thr ile gly arg thr tyr val tyr asp asn lys tyr
ATG CCG GAT TAT TCA TAC CGT CCC ACC ATC GGG CGT ACC TAC GTG TAC GAC AAC AAG TAC
+1 MsPI pAc360 ?LpAc311
tyr lys asn leu gly
TAC AM AAT TTA GGT
ala val ile lys asn ala lys arg lys lys his phe ala g^lu his
GCC GTT ATC MG MC GCT MG CGC MG AAG CAC TTC GCC GAA CAT
76
pAc101l
asp asn tyr leu val ala glu as4pro phe leu gly pro gly lys
GAC AAC TAC CTA GTG GCT GAG GAT CCT TTC CTG GGA CCC GGC AAG
151 BaniH MspI
5au3A
glu ile glu glu ala
GAG ATC GAA GAG GCT
gZi3A
Taq I
thr leu asp pro leu
ACC CTC GAC CCC CTA
TaqI
asn gln lys leu thr leu phe lys glu ile
AAC CAA AAA CTC ACT CTC TTC MG GM ATC
arg asn val lys pro asp thr met lys leu val val gly trp lys gly lys glu phe tyr arg glu thr trp thr
CGT MT GTT AAA CCC GAC ACG ATG MG CTT GTC GTT GGA TGG AAA GGA AAA GAG TTC TAC AGG GAA ACT TGG ACC
226 Hindill
Alul
FIG. 1. Nucleotide and amino sequence of the 5' end of the polyhedrin gene. The DNA sequence of a
segment of the polyhedrin gene and 5' flanking region is presented as the sense (+) strand and was determined
using the dideoxy termination procedure (29). The sequence around the 5' end of the polyhedrin gene was
determined from the following overlapping templates: the minus strand beginning at the HindIll or BamHI sites
in pAclOl, the minus strand beginning at the synthetic BamHI sites in pAc311, pAc360, and pAc380, and the plus
strand beginning at the BamHI or HindIll sites in pAclOl (Fig. 2). The location of the natural BamHI site in the
transfer vector pAclOl and positions of the BamHI linkers in pAc311, pAc360, and pAc380 are indicated by
arrows. The box at -58 marks the bases that code for the 5' end of polyhedrin mRNA (34). The rectangles
centered at -78 and -110 mark the nucleotides that resemble the canonical TATA and CAAT box sequences,
respectively. The repeated CACAAACT sequences upstream from the CAAT box are underlined. The
translational start signal for polyhedrin is assigned position +1.
an agarose gel. The purified fragments were ligated to
EcoRI- plus-BamHI-digested pUC8 and then used to
transform JM83 cells. The sizes of the deletions in the
resulting clones were estimated by restriction enzyme
analysis and in some cases by DNA sequencing. The
XhoI-to-BamHI fragment in pAC101 (located at 1,900
to 4,210 bases in EcoRl-I; 34) was removed and
replaced with XhoI-to-BamHI linker fragments from
several different pB' mutant plasmids, using standard
cloning procedures, to produce the modified transfer
vectors pAc311, pAc360, and pAc380. These plasmids
have single BamHI cloning sites in the polyhedrin gene
at the locations indicated in Fig. 1.
DNA sequencing. AcNPV restriction fragments were
cloned into M13mp8 or M13mp9 (19), and the single-
stranded recombinant phage DNAs were purified and
used as templates in the chain-termination sequencing
method (29). The sequence was determined from over-
lapping DNA templates, and all autoradiographs were
read independently at least twice. The sequence
across all restriction enzyme sites in the polyhedrin
gene was also determined.
RESULTS
Nucleotide sequence of the polyhedrin promot-
er and the construction of transfer vectors. The
nucleotide sequence of the 5' end of the polyhe-
drin-coding region and 200 bases upstream from
the start of translation is shown in Fig. 1. The
site that specifies the 5' end of polyhedrin
mRNA has been mapped in a high-resolution Si
nuclease experiment to 220 bases in the 5'
direction from the single BamHI site that maps
within the gene (Fig. 1; 34). An ATG translation-
al start signal (the A residue was assigned posi-
tion + 1) was located ca. 58 bases from the
transcription start site, followed by an open
reading frame for 244 amino acids. Proline is
known to be the amino-terminal residue for
AcNPV polyhedrin (J. Maruniak, Ph.D. thesis,
University of Texas, Austin, 1980) and was the
penultimate N-terminal amino acid predicted
from the DNA sequence (Fig. 1). The predicted
sequence for AcNPV polyhedrin (Fig. 1) was 80
to 90o homologous with several other NPV
polyhedrins (28). The complete sequence of the
AcNPV polyhedrin gene will be presented in
another report (Hooft van Iddekinge et al., in
press). Located about 78 and 110 bases up-
stream from the translational start site were
sequences that resembled, respectively, the ca-
nonical "TATA" and "CAAT" boxes found in
similar positions in many eucaryotic structural
genes (see reference 5 and references therein).
Centered at -128 and -142 were the direct
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FIG. 2. Location of BamHI cloning sites in the transfer vectors pAclOl, pAc311, pAc360, and pAc380
illustrated relative to the coding sequences (open rectangles), the putative cap site, and the TATA box sequences
of the polyhedrin gene. The interferon fragment cloned into these BamHI sites is shown in the lower panel. When
cloned into pAclOl and pAc360, the interferon coding sequences (open rectangle) are in the same reading frame
as polyhedrin, and when cloned into pAc311 they are not. The polyhedrin-interferon hybrid proteins and 17K
non-glycosylated and 20.5K glycosylated IFN-1 proteins produced by AcNPV expression vectors are indicated.
Interferon was produced by AcNPV expression vectors, and the activity was measured as follows. S. frugiperda
cells were infected at 20 PFU per cell with AcNPV or AcNPV expression vectors. For infection, 4 x 106 S.
frugiperda cells were seeded in 4 ml of medium in a 25-cm2 culture flask and then infected for 1 h at 23°C with 1
ml of virus inoculum. Infected cells were washed, 4 ml offresh medium plus 10% FBS were added, and the flasks
were incubated at 27°C for 48 h. The media were removed and centrifuged for 10 min at 3,000 x g. The
supernatant from each was centrifuged at 100,000 x g for 30 min at 4°C and then stored at -80°C until assayed.
Infected cells were washed in phosphate-buffered saline, suspended at 2 x 106 cells per ml, and then disrupted by
mixing with an equal volume of 7 M guanidine hydrochloride. Media and disrupted cells were assayed for
interferon by the plaque-reduction assay and compared with an international interferon reference standard (18).
repeated nucleotides CACAAACT. These se-
quences may be analogous to the tandemly
repeated promoter element (-100 region) in, for
example, the promoter region of rabbit beta
globin (5). The AcNPV polyhedrin gene has a
58-base nontranslated leader sequence preced-
ing the translational start codon, and, as suggest-
ed from S1 nuclease experiments of AcNPV
polyhedrin mRNA (34) and R-loop mapping of
another NPV polyhedrin mRNA (27), these
were no intervening sequences.
The AcNPV genome has no known unique
restriction sites into which genes can be conve-
niently introduced in a site-specific manner. To
incorporate the gene for IFN-P into the viral
genome adjacent to the polyhedrin promoter, we
first constructed chimeric plasmid vectors
(transfer vectors). Each of these has both a
cloning site near the polyhedrin promoter and
flanking viral DNA linked to the E. coli plasmid
pUC8. EcoRI fragment I was cloned into the
EcoRI site in pUC8. There are three BamHI
sites on this plasmid, one of which is located at
position + 175 in the polyhedrin gene (Fig. 1).
The other two BamHI sites were removed,
resulting in the transfer vector pAclOl. From
the nucleotide sequence of polyhedrin and inter-
feron, it can be determined that the IFN-P
protein-coding sequences, when inserted into
the unique BamHI cloning site in pAclOl, would
be in the same translational reading frame as
polyhedrin.
To investigate the importance of various poly-
hedrin gene sequences in the expression of IFN-
1B, the transfer vector pAclOl was modified to
have BamHI cloning sites at other positions near
the 5' end of the polyhedrin gene. Deletions
were produced between the natural BamHI site
at + 175 and the polyhedrin promoter in pAclOl,
and a synthetic oligonucleotide containing a
BamHI recognition site was added at the points
of deletion. The transfer vectors pAc311 and
pAc360 have BamHI sites at +35 and +34
bases, respectively, downstream from the start
site of polyhedrin translation (Fig. 1). The vector
pAc380 has a BamHI cloning site at -59, which
Transter Vectors
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is the putative cap site for polyhedrin mRNA
(Fig. 1).
The nucleotide sequence for IFN-, and the
location of various transcription and translation
signals are known (4, 10, 23). A 767-base-pair
HinclI fragment from a genomic clone of human
IFN-P (pBR13; 11) (containing the entire protein
coding sequences for IFN-,B, three additional
bases before the ATG translation start signal,
and all of the nontranslated 3' sequences includ-
ing the signal for polyadenylation [23]) was
cloned into the HincII site of pUC8. This frag-
ment was joined to synthetic octanucleotide
BamHI linkers and then cloned into the unique
BamHI sites in pAclOl, pAc311, pAc360, and
pAc380 (Fig. 2). Plasmids were examined, using
various restriction enzymes to obtain the trans-
fer vectors in which IFN-, was oriented in the
same 5' to 3' direction as the polyhedrin gene,
hereafter referred to as pAc101-IFN-,, pAc311-
IFN-P, pAc360-IFN-P, and pAc380-IFN-,. As
an example, pAc380 and the location and orien-
tation of the interferon fragment in this transfer
vector are shown in Fig. 3.
Construction of AcNPV expression vectors.
Next, we transferred these hybrid polyhedrin-
interferon genes to the AcNPV genome. AcNPV
DNA was mixed with each of the transfer vec-
tors containing the hybrid genes, and S. frugi-
perda cells were transfected as described previ-
ously (30). Recombinant AcNPV with insertions
of IFN-P DNA was obtained from the resulting
viral progeny by screening for plaques formed
by viruses that did not produce occlusions (0-
mutants). Of the viral plaques resulting from the
virus produced in cells cotransfected with viral
and plasmid DNAs, an average of 0.5% were
formed from putative recombinant 0- viruses.
DNA restriction analysis demonstrated that
each had the addition of IFN-P DNA at the
appropriate location in EcoRI fragment I and
that no other changes in the viral DNAs were
detected (data not shown). The recombinant
viruses were, therefore, defective in the produc-
tion of occlusions due to insertional inactivation
of the polyhedrin gene. Referred to here as the
viral expression vectors Ac101-IFN-,, Ac311-
IFN-P, Ac360-IFN-P, and Ac380-IFN-P they
resulted from recombination between AcNPV
and the corresponding IFN-P transfer vectors.
The details of the relatively simple screening
procedure used to select for AcNPV recombi-
nants are described in a recent report (30).
Biologically active interferon is produced and
secreted in cells infected with recombinant
AcNPV. Cells infected with AcNPV-interferon
expression vectors underwent morphological
changes that are typical of 0- viral infections
(30). The entire infection process, including viral
protein synthesis, viral assembly, and partial
SatE//If d 1
Q96
pAc 380
Xhol
1.90 Hind III6.0?
t f t
Arrowsmrk the ppolyhaedron aino h oye
The~~~~~~~aHBaHI clonings tet40 stepoiina) hc
adeletion from p+175to-9(i.2 wsitoue
4.00~~~~49
TFN-,Ibfragmenscritandhn cloneng site
BamHi BamHi
FIG. 3. AcNPV transfer vector pAc38O and IFN-1.
Arrows mark the approximate location of the polyhe-
drin mRNA coding sequences, and the positions of
certain restriction sites are indicated in kilobase pairs.
The BamHI cloning site at 4.00 is the position at which
a deletion from + 175 to -59 (Fig. 2) was introduced
and replaced by a BamHi octanucleotide linker.
BamHl linkers were added to a 767-base-pair Hincill
IFN-b fragment and then cloned into the BamHl site
in pAc380, producing the recombinant transfer vector
pAc380-IFN-l3. IFN-P3 protein-coding sequences areindicated by the rectangle, and the long arrow marks
the direction of transcription.
cell lysis, was complete by ca. 72 h p.i. There
was a marked reduction in protein synthesis
between 50 and 60 h p.i., and cell lysis was first
detected at about 50 h p.i. The titer of recombi-
nant AcNPV-infected cells reached a maximum
of ca. 5 x 108 PFU/ml of medium, which is
typical of AcNPV-infected cells. Thus, the in-
sertion of interferon DNA into the polyhedrin
gene had no major effect on the replication of
these recombinant viruses.
To determine whether the AcNPV polyhedrin
gene sequences could promote expression of
IFN-13, the level of interferon activity was mea-
sured in S. frugiperda cells infected with each of
the AcNPV expression vectors. B3ecause inter-
feron is normally secreted, media from infected
cells were also tested for interferon activity. We
used the virus plaque-reduction assay (18) in
WISH cells challenged with vesicular stomatitis
virus to determine interferon activity. If virus
particles were removed by centrifugation, no
interferon activity was measured in medium
MOL. CELL. BIOL.
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Time (hours)
FIG. 4. Production of interferon activity in infected
cells S. frugiperda cells were infected with AcNPV
(i), Ac360-IFN-P (0), or Ac380-IFN-1 (A). The
interferon activity in the medium was measured at 0,
12, 20, 24, 36, 42, and 48 h p.i. as described for Fig. 2.
from wild-type AcNPV-infected cells. However,
if AcNPV-containing media were used during
interferon assays 1,000 to 3,000 U of interferon
per ml was produced, indicating that AcNPV
virions apparently can induce the expression of
endogenous interferon in WISH cells. Because
many species of enveloped viruses are known to
induce interferon production in human cells (39),
these results were expected. To avoid this ef-
fect, all subsequent samples were centrifuged
before testing.
Significant levels of interferon were detected
by 48 h p.i. in cells infected with all of the
expression vectors. Ac380-IFN-P, in which in-
terferon was inserted about 19 bases down-
stream from the polyhedrin TATA box se-
quences, produced the highest levels (Fig. 2).
Very high levels were also produced by Ac360-
IFN-P, in which interferon was located at +34
and in the same translational reading frame as
polyhedrin. In contrast, very low levels of activ-
ity were produced in cells infected with AclOl-
IFN-g3 (Fig. 2), in which interferon was in the
same reading frame as polyhedrin but located
much further downstream at +175. Somewhat
unexpected were the moderate levels of interfer-
on activity produced by cells infected with
Ac311-IFN-P (Fig. 2), in which interferon was
inserted at +35 and consequently not in the
correct reading frame for polyhedrin. Described
later is an examination of proteins produced in
infected cells, which helps to explain these re-
sults.
The kinetics of interferon induction were ex-
amined in S. frugiperda cells infected with the
expression vectors Ac360-IFN-P and Ac380-
IFN-P. Samples of the medium were taken from
0 to 48 h p.i. and stored at -80°C until assayed
for interferon. The medium from Ac380-IFN-,
infected cells had about 10,000 IU of interferon
per ml at 12 h p.i., and this level increased to a
maximum of nearly 5 x 106 IU/ml by 42 h p.i.
(Fig. 4). A similar pattern of induction was
observed in Ac360-IFNP-infected cells (Fig. 4).
The synthesis of polyhedrin in AcNPV-infected
cells is known to follow a similar temporal
pattern of expression (see reference 33 and
references therein).
Effects of IFN-f8 on S. frugiperda cells. A
potential limitation in using animal virus expres-
sion vectors for interferons (7) is that interferon
itself can impose restraints upon the level of
expression by interfering with the replication of
the virus vector. The high levels of IFN-P pro-duced in S. frugiperda cells, using AcNPV as a
vector, and the normal titer of virus that was
produced suggested that interferon does not
affect AcNPV replication. To examine whether
human IFN-3 induced an antiviral state in S.
frugiperda cells, the following experiment was
conducted. Cells (2 x 106) were treated for 12 h
with, per ml, up to 5 x 106 IU of interferon
produced in Ac380-IFN-p-infected cells or 5 x
103 IU of an international standard of IFN-p,
and the treated cells were infected with 100 PFU
of AcNPV or Ac380-IFN-13. Exposure of the
cells to human interferon had no measurable
effect on the number of virus plaques that devel-
oped.
Protein synthesis in cells infected with AcNPV
expression vectors. In the expression vector
Ac380-IFN-3 the nucleotides between -59 and
+ 175 were deleted and replaced by an IFN-1
gene fragment containing the interferon ATG
translational start signal preceded by three bases
and a synthetic BamHI linker (Fig. 2 and 3). This
placed the interferon gene ATG protein start
signal approximately the same number of bases
downstream from the polyhedrin gene TATA
box as the polyhedrin transcriptional start site,
leaving little, if any, nontranslated leader at the
5' end of the predicted mRNA for this hybrid
gene. High levels of interferon activity were
measured in the medium of Ac380-IFN-P-infect-
ed cells, indicating that the polyhedrin promoter
efficiently directed the transcription of this gene.
At 30 and 48 h p.i., two polypeptides of 17,000
(17K) and 20.5K molecular weight were being
made in Ac380-IFN-P but not in AcNPV-infect-
ed cells (Fig. 5A and B). The sizes of non-
glycosylated and glycosylated human IFN-p
proteins are reported to be comparable to the
17K and 20.5K polypeptides, respectively (3,
15). At 30 h p.i., the 17K polypeptide was being
made in Ac360-IFN-13-infected cells (Fig. 5A;
see Fig. 7), and by 48 h p.i., both 17K and 20.5K
polypeptides were detected (Fig. SB). Only the
17K polypeptide could be detected in Ac311-
IFN-,-infected cells at 30 and 48 h p.i. (data not
shown). An abundantly produced 23.5K protein
was observed in Ac3604IFN-13-infected cells
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FIG. 5. Recombinant interferon produced in cells at (A) 30 or (B) 48 h p.i. (A) S. frugiperda cells were
infected with AcNPV (Ac), Ac380-IFN-0, Ac360-IFN-,B, AclOl-IFN-P, and dIlOA (a deletion mutant of AcNPV
that produces a truncated polyhedrin protein) and then labeled for 30 min with [3H]leucine at 30 h p.i. (B) S.
frugiperda cells were infected with AcNPV (Ac), Ac380-IFN-13, and Ac360-IFN-P and then labeled for 30 min
with [3H]leucine at 48 h p.i. Total cell lysates were electrophoresed on a sodium dodecyl sulfate-12%
polyacrylamide gel; the gel was impregnated with En3Hance (New England Nuclear Corp., Boston, Mass.) and
exposed to X-ray film for 2 days at -800C. The molecular weights (x 103) of certain polypeptides are indicated.
(Fig. 5A and B) and has the size expected for a
hybrid protein consisting of the entire interferon
protein, including the 21 amino acid signal pep-
tide plus an additional 14 amino acids derived
from the first 10 codons of the polyhedrin gene
and the BamHI linker sequences (Fig. 1 and 2).
In the expression vector AclOl-IFN-P, the
interferon fragment was inserted into the natural
AcNPV BamHI site at + 175 in the same transla-
tional reading frame as polyhedrin. A putative
hybrid 32K polypeptide was made in cells infect-
ed with this expression vector (Fig. 5). The size
of the protein was as predicted from the DNA
sequence.
Immunological identification of recombinant
products. The 17K and 20.5K proteins being
made in Ac380-IFN-P- and, to a lesser extent,
Ac360-IFN-p-infected cells reacted with human
IFN-P monoclonal antibody (Fig. 6C). The auto-
radiogram shown in Fig. 6 is a 6-h exposure, and
the reaction of IFN-1 antibody to the 20.5K
protein was more obvious with longer exposure
times. The reduced reaction of this antibody to
the 20.5K protein as compared with that to the
17K protein was in part due to the fact that 17K
accumulates to higher levels in cells than does
20.5K (data not shown). In addition, the anti-
body may be reacting to an epitope on the 17K
polypeptide that is partially masked by, for
example, glycosylation of the 20.5K polypep-
tide. The putative hybrid 23.5K and 32K pro-
teins also reacted with IFN-, antibody (Fig.
6C). Polyclonal antibody to polyhedrin recog-
nized the 10 amino acids of the 23.5K protein
and the 57 amino acids of the 32K protein that
would be predicted from the DNA sequence to
be present at the N-terminal ends of the hybrid
proteins (Fig. 6B).
Glycosylation of IFN-,B in infected cells. Tuni-
camycin is a specific inhibitor of glycosylation
which prevents the assembly of glycoproteins
(38). The inhibitor has been used to produce
nonglycosylated IFN-1 (42) and is effective in
AcNPV-infected S. frugiperda cells (36). In the
presence of tunicamycin, a 64K AcNPV glyco-
protein (6) was missing and a new protein of58K
was present (Fig. 7), indicating that the concen-
tration of inhibitor used in this experiment (5 ,ug/
ml) was sufficient to block glycosylation of this
protein. Tunicamycin had little effect on the
synthesis of the 17K IFN-0 or the 23K and 32K
hybrid proteins in Ac360-IFN-0- and AclOl-
IFN-0-infected cells (Fig. 7). However, no
20.5K IFN-1 was produced in the presence of
tunicamycin in cells infected with Ac360-IFN-,
(Fig. 7) or Ac380-IFN-0 (data not shown).
To further demonstrate that 20.5K IFN-3 was
gylcosylated, Ac380-IFN-,-infected cells were
labeled late in infection with [3H]mannose. The
20.5K IFN-1 and three additional proteins were
MOL. CELL. BIOL.
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FIG. 6. Immunological identification of interferon
and polyhedrin-interferon hybrid proteins. At 40 h p.i.,
total-cell lysates from AcNPV (Ac)-, Ac380-IFN-1-,
Ac360-IFN-1-, and Acl0l-IFN-13- infected cells were
electrophoresed on a sodium dodecyl sulfate-12%
polyacrylamide gel, transferred by diffusion to two
nitrocellulose filters, and incubated with either polyhe-
drin antiserum or IFN-P monoclonal antibody as de-
scribed previously (32). Specifically bound antibody
was detected with "2-I-labeled protein A, and the
filters were exposed to X-ray film at -80°C for 6 h with
the aid of an intensifying screen. (A) Autoradiogram of
infected cells labeled with [3H]leucine at 40 h p.i. as
described for Fig. 5. The molecular weights (x103) of
certain proteins are marked.
the major mannose-containing glycoproteins la-
beled in Ac380-IFN-P-infected cells (Fig. 8). A
summary of the 17K non-glycosylated and
20.5K glycosylated IFN-1 and the polyhedrin-
IFN-, hybrid proteins produced by the various
expression vectors is given in Fig. 2.
DISCUSSION
We have demonstrated that exceptionally high
levels of interferon were produced in cells in-
fected with a recombinant AcNPV expression
vector in which the gene for IFN-3 was placed
under the transcriptional control of the polyhe-
drin promoter. Based on the specific activity of
purified interferon (14), we estimate that ca. 10
p.g of interferon was secreted by 106 S. frugi-
perda cells infected with Ac380-IFN-,B. In
Ac380-IFN-,, the coding sequences for interfer-
on were linked to the polyhedrin promoter at
-59 (ca. 19 bases downstream from the canoni-
cal TATA sequences), suggesting that (i) polyhe-
drin gene sequences upstream from -59 were
primarily responsible for the regulation of tran-
scription and (ii) the 58-base nontranslated 5'-
leader sequence of polyhedrin was not absolute-
ly required for efficient expression.
Cleavage of the signal peptide of pre-IFN-,3 is
thought to be essential for producing biologically
active, mature IFN-, (3, 37). Therefore, the
polyhedrin-IFN-,B hybrid proteins produced by
the vectors Ac360-IFN-1 and AclOl-IFN-p,
which almost certainly still have the pre-IFN-3
signal peptide as well as additional polyhedrin
sequences, were most likely not biologically
active. Much of the mature IFN-1 produced by
Ac360-IFN-0 was probably a result of the re-
moval of the signal peptide from some of the
23.5K hybrid gene product, in spite of the fact
that the 21-amino acid signal sequence was an
additional 14 amino acids from the N-terminal
end of the protein. Sequence analysis of IFN-,
and the hybrid proteins will be needed to con-
firm these speculations. Mature IFN-p may
have also been produced by Ac360-IFN-0 by
another mechanism. It can be predicted from the
scanning model for eucaryotic translation initia-
tion (16) that the polyhedrin protein start se-
quence AUAAUGC is less favorable for initia-
IFN IFN
M AC 380 101
+ - + 4+ Tunicamycin
64-
-
- -
33- OS -
-32
-~
~ 3; 360
23.5- _
20L.-
17-1
i-2 0.
...
',A- 17
w ~ ~ b1
.W b~~~~~~~~~~~~~~~~~~~~~~~~~~~..
FIG. 7. Effects of tunicamycin on the synthesis of
interferon At 30 h p.i. mock (M)-, AcNPV (Ac)-,
Ac360-IFN-1-, and Acl0l-IFN-f- infected cells were
labeled with [3H]leucine for 30 min in the presence or
absence of 5 ,ug of tunicamycin per ml. Infected cells
were pretreated for 10 h in medium plus 5 pLg of
tunicamycin per ml before being labeled in the pres-
ence of the inhibitor. A longer exposure of Ac360-
IFN-13-labeled proteins is shown in the right panel.
The molecular weights (x103) of certain proteins are
marked.
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FIG. 8. Incorporation of [3H]mannose into recom-
binant interferon. AcNPV (Ac)- and Ac380-IFN-p-
infected cells were labeled for 1 h at 40 h p.i. with
[3H]leucine or [3H]mannose. Total cell lysates were
electrophoresed on sodium dodecyl sulfate-12% poly-
acrylamide gel. The molecular weights (x 103) of the
polypeptides that were labeled with [3H]mannose are
indicated.
tion than is the optimal sequence PuNNAUGG.
Accordingly, this suboptimal sequence would be
expected to allow some ribosomes to advance to
the next potential initiator codon. Therefore,
translation of 23.5K hybrid mRNA in Ac360-
IFN-p infected cells may have occasionally initi-
ated not at the first (polyhedrin) AUG but at the
second (interferon) AUG. The fact that IFN-p
was produced by Ac311-IFN-1 is good evidence
that this occurs, as interferon in this vector was
in a different reading frame from polyhedrin and
translation initiation from the second AUG is the
most likely explanation for these results.
Linking interferon to an efficient promoter
explains only in part why high levels of interfer-
on were produced. Another important factor
was the lack of antiviral activity on the AcNPV
vector itself. The millions of interferon units
produced per milliliter in our system had no
measurable effect on virus yields, whereas only
100 U of interferon per ml reduces the yield of
simian virus 40 by up to 80% (7), limiting the use
of this and similarly affected vertebrate animal
viruses as vectors for interferon.
AcNPV and other baculoviruses should prove
to be important vectors for the production of
cloned gene products in insect cells or organ-
isms. The invertebrate cell will provide a unique
MOL. CELL. BIOL.
biochemical environment for the production of
foreign products and will complement vertebrate
and procaryotic host-vector systems. Potential-
ly, any gene could be linked to the polyhedrin
promoter, incorporated into the AcNPV
genome, and efficiently expressed in infected
cells. We are currently investigating whether
genes with intervening sequences will be cor-
rectly processed in this system, whether the
promoter for the highly expressed AcNPV 10K
gene (34) can be used in place of, or in the
addition to, the polyhedrin promoter, and
whether there are limits on the size of the DNA
that can be incorporated into AcNPV expression
vectors.
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ADDENDUM IN PROOF
After this report was submitted for review a study
by Remaut et al. (E. Remaut, P. Stanssens, and W.
Fiers, Nucleic Acids Res. 14:4677-4688, 1983) was
published which described the synthesis of mature
IFN-1 under the transcriptional control of a phage
lambda promoter in E. coli cells at a level similar to
that which was reported here.
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